M&A Deal Summary |
|
---|---|
Date | 2015-03-02 |
Target | American Medical Systems |
Sector | Medical Products |
Buyer(s) | Boston Scientific |
Sellers(s) | Endo International |
Deal Type | Divestiture |
Deal Value | 1.6B USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1979 |
Sector | Medical Products |
Employees | 48,000 |
Revenue | 14.2B USD (2023) |
Boston Scientific is a medical technology company. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 30 of 65 |
Sector (Medical Products) | 19 of 49 |
Type (Divestiture) | 4 of 11 |
State (Minnesota) | 4 of 6 |
Country (United States) | 25 of 50 |
Year (2015) | 1 of 5 |
Size (of disclosed) | 5 of 34 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-05-27 |
StarMedTec
Starnberg, Germany StarMedTec GnbH develops, manufactures and sells medical lasers for applications in urology, surgery and other medical areas. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-04-01 |
Xlumena
Mountain View, California, United States Xlumena, Inc. is a medical device company that develops, manufactures and sells minimally invasive devices for Endoscopic Ultrasound (EUS) guided transluminal drainage of targeted areas within the gastrointestinal tract. |
Buy | $63M |
Category | Company |
---|---|
Founded | 1920 |
Sector | Medical Products |
Employees | 3,103 |
Revenue | 2.9B USD (2020) |
Endo International is a pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain, bladder cancer, prostate cancer and the early onset of puberty in children, or central precocious puberty (CPP). Endo International was incorporatted in 1920 and is based in Dublin, Ireland.
DEAL STATS | # |
---|---|
Overall | 2 of 4 |
Sector (Medical Products) | 2 of 2 |
Type (Divestiture) | 2 of 4 |
State (Minnesota) | 1 of 1 |
Country (United States) | 2 of 2 |
Year (2015) | 1 of 1 |
Size (of disclosed) | 1 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-01-29 |
Auxilium Pharmaceuticals
Malvern, Pennsylvania, United States Auxilium Pharmaceuticals (AUXL) develops and markets pharmaceutical products that focus on urology and sexual health. This includes commercialization of Testim Gel for male hypogonadism (low testosterone) and development of Xiaflex for connective tissue disorders such as Duputrens contracture and Peyronies disease. |
Buy | $2.6B |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-05-18 |
Par Pharmaceutical Companies
Woodcliff Lake, New Jersey, United States Par Pharma specializes in developing, licensing, manufacturing, marketing and distributing generic drugs. |
Buy | $8.1B |